Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC.
JTO Clin Res Rep
; 4(11): 100572, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37954964
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
JTO Clin Res Rep
Year:
2023
Document type:
Article
Affiliation country:
Corea del Sur